AC
MRNA icon

Allstate Corporation’s Moderna MRNA Stock Holding History

Allstate Corporation’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Sell
29,980
-11,346
-27% -$587K 0.02% 457
2026
Q1 		$2.1M Buy
+41,326
New +$1.93M 0.02% 498
2025
Q2 		– Sell
-14,448
Closed -$410K – 426
2025
Q1 		$410K Buy
14,448
+4,934
+52% +$175K 0.01% 534
2024
Q4 		$396K Buy
+9,514
New +$455K 0.01% 540
2023
Q1 		– Sell
-14,190
Closed -$2.55M – 437
2022
Q4 		$2.55M Buy
14,190
+179
+1% +$29.3K 0.08% 170
2022
Q3 		$1.66M Buy
14,011
+335
+2% +$50.8K 0.05% 220
2022
Q2 		$1.95M Sell
13,676
-4,642
-25% -$664K 0.06% 189
2022
Q1 		$3.15M Sell
18,318
-8,422
-31% -$1.42M 0.08% 167
2021
Q4 		$6.79M Buy
26,740
+20,163
+307% +$5.9M 0.13% 119
2021
Q3 		$2.53M Sell
6,577
-436
-6% -$161K 0.1% 95
2021
Q2 		$1.65M Sell
7,013
-891
-11% -$159K 0.06% 178
2021
Q1 		$1.03M Buy
7,904
+816
+12% +$118K 0.03% 303
2020
Q4 		$740K Buy
7,088
+1,180
+20% +$119K 0.02% 349
2020
Q3 		$418K Buy
5,908
+1,757
+42% +$123K 0.01% 477
2020
Q2 		$267K Buy
+4,151
New +$227K 0.01% 604

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Allstate Corporation's MRNA Position: Q2 2026 in Review

Allstate Corporation reduced its Moderna (MRNA) stake by 27% in Q2 2026, selling an estimated $587K and leaving 29,980 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #457.

Allstate Corporation first reported a position in MRNA in Q2 2020 and has held it in 15 quarters since. The position peaked at $6.79M in Q4 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Allstate Corporation held 29,980 shares of Moderna worth $2.1M as of Q2 2026.
  • Allstate Corporation sold 11,346 Moderna shares in Q2 2026, an estimated $587K.
  • Moderna made up 0.02% of Allstate Corporation's portfolio in Q2 2026, its #457 holding.
  • Allstate Corporation first reported a position in Moderna in Q2 2020 and has held it in 15 quarters since.
  • Allstate Corporation's Moderna position peaked at $6.79M in Q4 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.